XTX Topco’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2K Buy
22,493
+3,626
+19% +$3.12K ﹤0.01% 3574
2025
Q4
$10.8K Buy
18,867
+864
+5% +$781 ﹤0.01% 3175
2025
Q3
$17.7K Buy
18,003
+6,442
+56% +$5.83K ﹤0.01% 2350
2025
Q2
$8.23K Buy
+11,561
New +$8.08K ﹤0.01% 2241
2024
Q2
Sell
-12,185
Closed -$18.8K 1876
2024
Q1
$18.8K Buy
+12,185
New +$16.9K ﹤0.01% 1615
2022
Q2
Sell
-717
Closed -$48K 855
2022
Q1
$48K Buy
+717
New +$52K 0.02% 594

Other funds holding BFRI

XTX Topco's BFRI Position: Q1 2026 in Review

XTX Topco increased its Biofrontera (BFRI) stake by 19% in Q1 2026, buying an estimated $3.12K and bringing the position to 22,493 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

XTX Topco first reported a position in BFRI in Q1 2022 and has held it in 6 quarters since. The position peaked at $48K in Q1 2022. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • XTX Topco held 22,493 shares of Biofrontera worth $18.2K as of Q1 2026.
  • XTX Topco bought 3,626 Biofrontera shares in Q1 2026, an estimated $3.12K.
  • Biofrontera made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3574 holding.
  • XTX Topco first reported a position in Biofrontera in Q1 2022 and has held it in 6 quarters since.
  • XTX Topco's Biofrontera position peaked at $48K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.